Aldevron
Contract development and manufacturing organization (CDMO) that produces plasmid DNA, mRNA, proteins and enzymes across research and cGMP quality grades. Offers integrated sequence-to-vial services including DNA template/vector design, engineered production strains, in vitro transcription and capping, LNP formulation, analytical development (including sequencing-based QC), aseptic fill/finish, process development and regulatory support. Operates multiple purpose-built manufacturing and R&D facilities in the U.S. and reports ISO and GMP inspection outcomes.
Industries
Nr. of Employees
medium (51-250)
Patents
Growth of bacterial host cells in gas permeable low-density polyethylene bags for production of plasmid DNA or recombinant molecules
US-11692159-B2
View Details
Growth of bacterial host cells in gas permeable low-density polyethylene bags for production of plasmid DNA or recombinant molecules
US-11692159-B2
View DetailsProducts
CRISPR nucleases (research and clinical grades)
High-fidelity and wild-type nucleases supplied at research and clinical quality grades to support gene editing programs.
IVT and capping enzymes
Enzymes for in vitro transcription and capping manufactured to support research through clinical manufacturing of RNA.
Viral vector plasmids (AAV & lentiviral)
Expression and helper plasmids used to generate high-titer viral vectors for research and clinical production.
Cloning backbones and empty vectors
License-free empty vector backbones for cloning and DNA template generation for IVT.
DNA/RNA reporter constructs and control mRNAs
Reporter constructs and control mRNAs for transfection, expression testing and assay development.
Plasmid preparation services (Maxi, Mega, Giga)
Research-grade plasmid preparation services with rapid turnaround options for discovery workflows.
CRISPR nucleases (research and clinical grades)
High-fidelity and wild-type nucleases supplied at research and clinical quality grades to support gene editing programs.
IVT and capping enzymes
Enzymes for in vitro transcription and capping manufactured to support research through clinical manufacturing of RNA.
Viral vector plasmids (AAV & lentiviral)
Expression and helper plasmids used to generate high-titer viral vectors for research and clinical production.
Cloning backbones and empty vectors
License-free empty vector backbones for cloning and DNA template generation for IVT.
DNA/RNA reporter constructs and control mRNAs
Reporter constructs and control mRNAs for transfection, expression testing and assay development.
Plasmid preparation services (Maxi, Mega, Giga)
Research-grade plasmid preparation services with rapid turnaround options for discovery workflows.
Services
End-to-end contract manufacturing and process development services for plasmid DNA, mRNA and recombinant proteins at research and cGMP quality grades.
Sequence-to-vial workflows including mRNA synthesis, LNP encapsulation and closed aseptic filling to produce drug product.
In-stock and custom-manufactured reagents and enzymes available at research, intermediate and cGMP quality grades.
Method development, validation and release testing for plasmid DNA, mRNA drug substance and drug product, including sequencing-based QC and LC-MS assays.
Parallel screening through optimization and scale-up manufacturing support for DNA, RNA and protein production.
Consulting and development services for selecting or engineering production strains and vector strategies to improve propagation and manufacturing yields of structured DNA elements.
End-to-end contract manufacturing and process development services for plasmid DNA, mRNA and recombinant proteins at research and cGMP quality grades.
Sequence-to-vial workflows including mRNA synthesis, LNP encapsulation and closed aseptic filling to produce drug product.
In-stock and custom-manufactured reagents and enzymes available at research, intermediate and cGMP quality grades.
Method development, validation and release testing for plasmid DNA, mRNA drug substance and drug product, including sequencing-based QC and LC-MS assays.
Parallel screening through optimization and scale-up manufacturing support for DNA, RNA and protein production.
Consulting and development services for selecting or engineering production strains and vector strategies to improve propagation and manufacturing yields of structured DNA elements.
Expertise Areas
- Plasmid DNA manufacturing and vector design
- mRNA drug substance and drug product development
- LNP formulation and delivery
- Viral vector plasmid support (AAV, lentiviral)
Key Technologies
- In vitro transcription (IVT) and enzymatic capping
- Lipid nanoparticle (LNP) formulation
- Next-generation (short-read) and long-read (nanopore) sequencing
- Small-backbone plasmid vector architectures
News & Updates
Renewed licensing and manufacturing agreement to expand access to an off-the-shelf lentiviral plasmid system across research and cGMP quality grades, including an optimized four-plasmid platform for lentiviral vector production.
Certificate of GMP Compliance from the competent authority of Germany for mRNA as an active ingredient in vaccine production for clinical trials (non-sterile).
Renewal of ISO 13485:2016 certification for development and manufacture of proteins and in vitro diagnostic-related proteins at the Madison facility.
Collaborative manufacture of an mRNA-based personalized CRISPR gene-editing drug product for an N-of-1 therapy; results presented in peer-reviewed and conference venues.
Report on preclinical data for a single-dose, room-temperature-stable AAV-based COVID-19 vaccine developed by an academic-industry consortium; Aldevron served as a manufacturing partner.
Facility expansion in Madison to add fermentation capacity and expand protein manufacturing capabilities.
Renewed licensing and manufacturing agreement to expand access to an off-the-shelf lentiviral plasmid system across research and cGMP quality grades, including an optimized four-plasmid platform for lentiviral vector production.
Certificate of GMP Compliance from the competent authority of Germany for mRNA as an active ingredient in vaccine production for clinical trials (non-sterile).
Renewal of ISO 13485:2016 certification for development and manufacture of proteins and in vitro diagnostic-related proteins at the Madison facility.
Collaborative manufacture of an mRNA-based personalized CRISPR gene-editing drug product for an N-of-1 therapy; results presented in peer-reviewed and conference venues.
Report on preclinical data for a single-dose, room-temperature-stable AAV-based COVID-19 vaccine developed by an academic-industry consortium; Aldevron served as a manufacturing partner.
Facility expansion in Madison to add fermentation capacity and expand protein manufacturing capabilities.